The leading causes remained heart disease, cancer, chronic lower respiratory diseases, unintentional injuries, stroke, and Alzheimer’s.
Earlier Thursday, Left's Citron Research called Express Scripts the "Philidor of the pharma industry."
Bristol-Meyers Squibb will pay millions to resolve allegations that it improperly promoted a schizophrenia treatment for unapproved uses.
British regulators fine Pfizer and distributor Flynn Pharma for increasing the cost of an epilepsy drug by as much as 2,600-percent.
WASHINGTON— Congress OKs bill speeding federal drug approvals, mapping $6.3 billion for biomedical research, battling drug addiction.
The "kill ratio" of suspects in The Philippines is much higher than in countries with comparable drug-related violence.
COLUMBUS, Ohio— Mount Carmel Health System in central Ohio is the first major health system to integrate its electronic health records with the state's prescription monitoring program that is intended to help reduce prescription drug abuse, officials said Friday. That means over 2,300 care providers at Mount Carmel's emergency departments and acute care...
Kenneth Frazier, the CEO of pharmaceutical giant Merck, says Trump's call to revamp Obamacare could prove useful.
CNBC’s Meg Tirrell talks to Kenneth Frazier, Merck CEO, at the fifth annual Forbes Healthcare Summit in New York about the future of drug pricing under the Trump administration as well as Alzheimer’s research.
CNBC's Meg Tirrell speaks with Express Scripts chief medical officer Dr. Steve Miller about the role of pharmacy benefits managers in drug pricing.
BOSTON— Changing marijuana laws aren't necessarily making weed more welcome in the workplace. For now, many employers appear to be sticking with their drug testing and personal conduct policies, even in states where recreational marijuana use is now permitted. Voters in California, Massachusetts, Maine and Nevada voted Nov. 8 to approve the use of recreational...
The White House said in a statement after the House vote: "The Senate should promptly pass this bill so that the President can sign it." The bill, sponsored by Republican Representative Fred Upton of Michigan, authorizes $4.8 billion to the National Institutes of Health and $500 million to the Food and Drug Administration to streamline the clinical trial process...
Nov 30- The U.S. House of Representatives is poised to pass a sweeping, $6.3 billion bill that supporters say will spur medical innovation, speed access to new drugs, expand access to mental health treatment and battle the opioid epidemic. The Senate is expected to vote on it next week. The Act, sponsored by Republican representative Fred Upton from Michigan,...
Bernie Williams, USAA Investment Solutions CIO, weighs in on how to best prepare your portfolio and your retirement.
Rodrigo Duterte has hit out at what he called Western threats to seek an International Criminal Court indictment over alleged summary executions.
Alex Tarrant, assistant editor at Dealreporter Europe, weighs in on Johnson & Johnson's proposed acquisition of Swiss biotechnology company Actelion.
Solanezumab, an experimental drug from Eli Lilly, failed to slow the loss of cognitive ability in patients with mild Alzheimer's disease.
Vamil Divan, Credit Suisse senior analyst, discusses Eli Lilly's failed Alzheimer's drug trial and the effect on its stock price.
CNBC's Josh Lipton reports the latest on how some in tech are planning to live a lot longer and thus are experimenting with anti-aging drugs and therapies.
The IOC says the 10, nine of whom hail from former Soviet nations, had all tested positive for various steroids.